Murillo-Rodríguez E, Arias-Carrión O

Language: Spanish
References: 38
Page: 421-425
PDF size: 103.56 Kb.

ABSTRACT

Narcolepsy is a chronic disease characterized by excessive somnolence, abrupt transitions from wakefulness to rapid eye movement sleep stage and cataplexy. Experimental evidence show that narcolepsy in humans is a neurodegenerative disease associated with the lost of hypocretin (HCRT) neurons in the lateral hypothalamus. Narcoleptic patients also display a significant diminution in HCRT contents of cerebrospinal fluid. In order to study narcolepsy, several experimental models have been developed. Murine and canine models currently allow us to study this disease. Our laboratory has developed a new experimental rat model of narcolepsy. This model allows us to study the disease from a histological and neurochemical perspective. Elsewhere we have reported that the use of the toxin hypocretin2/saporine (HCRT2/ SAP) selectively destroys hypocretinergic neurons. The loss of these neurons induces a similar behavioural profile as the one observed in other experimental models of narcolepsy. In the present review we describe an overview on narcolepsy, the hypocretinergic system, experimental models in narcolepsy and the use of transplants as an alternative therapeutic tool.

REFERENCES

1. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998;438:71-75.

2. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001;103:777-797.

3. España RA, Reis KM, Valentino RJ, Berridge CW. Organization of hypocretin/ orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 2005; 481(2):160-178.

4. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. USA: Proc Natl Acad Sci 1998;95 (1):322-327.

5. Peyron C, Tighe DK, Van den Pol AN, De Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.

6. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573– 585.

7. Chemelli JT, Willie CM, Sinton JK, Elmquist T, Scammell C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451.

8. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573–585.

9. Chemelli JT, Willie CM, Sinton JK, Elmquist T, Scammell C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451.

10. Hagan JJ, Leslie RA, P atel S, Evans ML, Wattam TA, Holmes S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999;96(19):10911-10916.

11. Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 2002;22(20):8850-8859.

12. Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Muhlethaler M, et al. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 2002;22(18):7835-7839.

13. Bayer L, Eggermann E, Serafin M, Saint-Mleux B, Machard D, Jones B, et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci. 2001;14(9):1571-1575.

14. Eggermann E, Serafin M, Bayer L, Machard D, Saint -Mleux B, Jones BE, et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001;108(2):177-181.

15. Takahashi K, Koyama y, Kayama Y, Yamamoto M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 2002;56(3):335-336.

16. Siegel JM. Hipocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol 2004;55:125-148.

17. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.

18. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.

19. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474.

20. Dalal MA, Schuld A, Haack M, Uhr M, Geisler P, Eisensehr I, et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001;56:1749-1751.

21. Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto H, et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002;11:91-93.

22. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-1562.

23. Nishino S, Ripley B, Overeem S, Lammers GJ and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.

24. Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-388.

25. Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001;57:2253-2258.

26. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-354.

27. Stirpe F, Gasper-Campani A, Barbieri L, Falasca A, Abbondanza A, Stevens WA. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle), and of Asparagus officinalis (asparagus) and from the latex of Hura crepitans L (sandbox tree). Biochem J 1983;216:617-625.

28. Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, kILDUFF ts, et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001;21(18):7273-7283.

29. Gerashchenko D, Blanco-Centurion C, Greco MA and Shiromani PJ. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin2-saporin on sleep in Long Evans rats. Neuroscience 2003;116:223-235.

30. Gerashchenko D, Murillo-Rodríguez E, Lin L, Xu M, Hallett L, Nishino S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 2003;184(2):1010-1016.

31. Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 2002;283(5):R1079-R1086.

32. Yamamoto Y, Ueta Y, Hara Y, Serino R, Nomura M, Shibuya I, et al. Postnatal development of orexin/hypocretin in rats. Brain Res Mol Brain Res. 2000 78:108-119.

33. Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Changes in CSF hypocretin-1 (orexin a) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001;12:993-997.

34. Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, et al. Fluctuation of extracellular hypocretin-1 (orexin a) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur J Neurosci 2001;14:1075-1081.

35. Desarnaud F, Murillo-Rodríguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, et al. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27(5):851-856.

36. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-166.

37. Mignot E, Nishino S. Emerging therapies in narcolepsy-cataplexy. Sleep 2005;28:754-763.

38. Arias-Carrión O, Murillo-Rodríguez E, Xu M, Blanco-Centurión C, Drucker- Colín R, Shiromani PJ. Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep 2004;27:1465-1470.